These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9160413)

  • 1. Speeds of action of single doses of formoterol and salbutamol compared with placebo in reversing methacholine-induced bronchoconstriction.
    Beach JR; Bromly CL; Avery AJ; Reid RW; Walters EH; Hendrick DJ
    Pulm Pharmacol; 1996 Aug; 9(4):245-9. PubMed ID: 9160413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the onset of action of salbutamol and formoterol in reversing methacholine-induced bronchoconstriction.
    van Noord JA; Smeets JJ; Maesen FP
    Respir Med; 1998 Dec; 92(12):1346-51. PubMed ID: 10197228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of treatment with formoterol on bronchoprotection against methacholine.
    Lipworth B; Tan S; Devlin M; Aiken T; Baker R; Hendrick D
    Am J Med; 1998 May; 104(5):431-8. PubMed ID: 9626025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
    Lipworth BJ; Aziz I
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study.
    Jonkers RE; Bantje TA; Aalbers R
    Respir Res; 2006 Dec; 7(1):141. PubMed ID: 17144916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil Aerolizer) with salbutamol (Ventodisk).
    Benhamou D; Cuvelier A; Muir JF; Leclerc V; Le Gros V; Kottakis J; Bourdeix I
    Respir Med; 2001 Oct; 95(10):817-21. PubMed ID: 11601748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol.
    Jones SL; Cowan JO; Flannery EM; Hancox RJ; Herbison GP; Taylor DR
    Eur Respir J; 2001 Mar; 17(3):368-73. PubMed ID: 11405513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma.
    Becker AB; Simons FE
    J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):891-5. PubMed ID: 2574732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
    van der Woude HJ; Boorsma M; Bergqvist PB; Winter TH; Aalbers R
    Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The duration of action of inhaled formoterol dry powder.
    Quebe-Fehling E; Brambilla R; Bromly CL; Fishwick K; Walters EH; Hendrick DJ
    Br J Clin Pract; 1996 Dec; 50(8):446-9. PubMed ID: 9039716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
    FitzGerald JM; Chapman KR; Della Cioppa G; Stubbing D; Fairbarn MS; Till MD; Brambilla R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):427-35. PubMed ID: 10069876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of salmeterol and formoterol in attenuating airway responses to short-acting beta2-agonists.
    van Veen A; Weller FR; Wierenga EA; Jansen HM; Jonkers RE
    Pulm Pharmacol Ther; 2003; 16(3):153-61. PubMed ID: 12749831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged protection against methacholine-induced bronchoconstriction by the inhaled beta 2-agonist formoterol.
    Ramsdale EH; Otis J; Kline PA; Gontovnick LS; Hargreave FE; O'Byrne PM
    Am Rev Respir Dis; 1991 May; 143(5 Pt 1):998-1001. PubMed ID: 1673830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study].
    Lebecque P; Vliers S; De Saint-Moulin T; Godding V
    Rev Mal Respir; 1994; 11(1):47-50. PubMed ID: 7907426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relief of dyspnoea by beta2-agonists after methacholine-induced bronchoconstriction.
    van der Woude HJ; Postma DS; Politiek MJ; Winter TH; Aalbers R
    Respir Med; 2004 Sep; 98(9):816-20. PubMed ID: 15338791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late asthmatic reaction decreased after pretreatment with salbutamol and formoterol, a new long-acting beta 2-agonist.
    Palmqvist M; Balder B; Löwhagen O; Melander B; Svedmyr N; Wåhlander L
    J Allergy Clin Immunol; 1992 Apr; 89(4):844-9. PubMed ID: 1348515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
    Haney S; Hancox RJ
    Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
    Aziz I; Lipworth BJ
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the speeds of action of salmeterol and salbutamol in reversing methacholine-induced bronchoconstriction.
    Beach JR; Young CL; Stenton SC; Avery AJ; Walters EH; Hendrick DJ
    Pulm Pharmacol; 1992 Jun; 5(2):133-5. PubMed ID: 1611231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.